Development and Use of Risk Minimization Action Plans: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 29, 2005
April 15, 2020
0c2f3726-2538-48fb-815a-44b28e56a090
Related Documents
E2E Pharmacovigilance Planning
Guidance DocumentApril 1, 2005Center for Drug Evaluation and Research
Premarketing Risk Assessment: Guidance for Industry
Guidance DocumentMarch 29, 2005Center for Drug Evaluation and Research
Q1E Evaluation of Stability Data
Guidance DocumentJune 8, 2004Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.